A Study to Determine the Bioequivalence of SCH 900068 Compared to Marketed Products (Protocol No. P07551)

NCT01236430 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

200

Enrollment

INDUSTRY

Sponsor class

Conditions

Hyperlipidemia

Interventions

DRUG: Ezetimibe
DRUG: Ezetimibe/atorvastatin 10mg/10mg FDC
DRUG: Atorvastatin 10mg
DRUG: Atorvastatin 80mg
DRUG: Ezetimibe/atorvastatin 10mg/80mg FDC

Sponsor

Organon and Co